期刊文献+

多潘立酮聚肌胞与奥美拉唑治疗Hp(-)慢性浅表性胃炎疗效的比较研究 被引量:20

The comparative study of efficacy on domperidone poly I:C and omeprazol in treatment of Helicobacter pylori negative chronic superficial gastritis
下载PDF
导出
摘要 目的比较多潘立酮聚肌胞与奥美拉唑治疗幽门螺杆菌(HP)阴性慢性浅表性胃炎的疗效。方法选择确诊为慢性浅表性胃炎且Hp(-)的患者89例,随机分为治疗组45例,对照组44例,治疗组采用多潘立酮聚肌胞治疗;对照组采用奥美拉唑治疗;3周后进行疗效观察;统计学处理。结果治疗组总有效41例,显效28例,对照组总有效30例,显效13例,治疗组总有效率及显效率均明显高于对照组;统计学处理,差异有统计学意义。结论治疗组的治疗效果优于对照组治疗效果。 Objective Compare domperidone polyI:C and omeprazol treatment Helicobacter pylori negative chronic superficial gastritis curative effect.Methods Selecting helicobacter pylori negative chronic superficial gastritis 89 cases diagnosed were randomly divided into the treatment group 45 cases and control group 44 cases,the treatment group using domperidone polyI:C treatment,the control group using omeprazol treatment,treated for 3 weeks,observation clinical manifestations.Results The total effective of treatment group got 41 cases,powerfully 28 cases and The total effective of control group got 29 cases,powerfully 11 cases.Conclusion Curative effects of treatment group are better than that of control group,Statistical processing,Significant differences.
出处 《四川医学》 CAS 2011年第8期1269-1270,共2页 Sichuan Medical Journal
关键词 慢性浅表性胃炎 幽门螺杆菌 多潘立酮 聚肌胞 奥美拉唑 chronic superficial gastritis Helicobacter pylori Domperidone PolyI:C Omeprazol
  • 相关文献

参考文献2

二级参考文献21

  • 1曾成,杨厚麟,吴锦燕,吴天秀.^(14)C-尿素呼气试验检测幽门螺旋杆菌临床应用价值的研究[J].四川医学,2006,27(8):798-799. 被引量:5
  • 2刘文忠.胃炎.见:王吉耀.内科学[M].北京:人民卫生出版社,2006,413-430
  • 3[1]Ferrero R L,Thiberge J M,Kansau I,et al.The GroES homolog of Helicobacter pylori confers protection immunity against mucosal infection in mice[J].Proc Natl Acad Sci U S A,1995,92(14):6499.
  • 4[2]Ferrero R L,Thiberge J M,Labigne A,et al.Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice[J].Gastroenterology,1997,113(1):185-194.
  • 5[3]Nedrud J G,Czinn S J,Blanchard T G.H.pylori Vaccines[A].In:LeeA,Kolesnikow T,eds.Helicobacter pylori:A global pathogen.Bailliere'Clinical Infectious Disease[M].London:Bailliere,1998.413-433.
  • 6[4]Blanchard T G,Czinn S J,Nedrud J G.Host response and vaccine development[ A].In:Westblom T U,Czinn S J,Nedrud J G,eds.Curr TopMicrobiol Immunol[M].Berlin:Springer Verlag,1999.181-213.
  • 7[8]Chen W,Shu D,Chadwick V S.Helicobacter pylori infection in interleukin-4-deficient and transgenic mice[J].Scand J Gastroenterol,1999,34(10):987-992.
  • 8[9]Smythies L E,Waites K B,Lindsey J R,et al.Helicobacter pylori-induced mucosal inflammation is Thl mediated and exacerbated in IL-4,butnot IFN-gamma,gene-deficient mice[J].J Immunol,2000,165(2):1022-1029.
  • 9[10]Weltzin R,Guy B,Thomas W D Jr,et al.Parenteral adjuvant activitiesof Escherichia coli heat-labile toxin and its B subunit for immunization ofmice against gastric Helicobacter pylori infection[ J].Infect Immun,2000,68(5):2775-2782.
  • 10[11]Lee A,Chen M.Successful immunization against gastric infection withHelicobacter species:use of a cholera toxin B-subunit-whole-cell vaccine[J].Infect Immun,1994,62(8):3594-3597.

共引文献5

同被引文献100

引证文献20

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部